Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Zibelman

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Immunotherapy|June 29, 2016
Checkpoint inhibitors for renal cell carcinoma: current landscape and future directionsMatthew Zibelman, Pooja Ghatalia, Daniel M Geynisman, et al.
Case Reports in Oncology|March 30, 2022
Clinical Utility of Liquid Biopsy to Identify Genomic Heterogeneity and Secondary Cancer Diagnoses: A Case ReportGregory Hemenway, Marni B Tierno, Reza Nejati, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Urology Case Reports|December 20, 2019
Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndromeKevin Zarrabi, Selma Masic, Christopher Schaefer, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov WebsitePooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Clinical Genitourinary Cancer|March 28, 2026
Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder CancerHal Rives, Jordan Fredette, Fern Anari, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer ContraindicationsJustine V Cohen, Adam Adika, Matthew Zibelman, et al.
Molecular Cancer Therapeutics|March 30, 2020
An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate CancerNancy A Dawson, Matthew Zibelman, Timothy Lindsay, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Immunotherapy|June 29, 2016
Checkpoint inhibitors for renal cell carcinoma: current landscape and future directionsMatthew Zibelman, Pooja Ghatalia, Daniel M Geynisman, et al.
Case Reports in Oncology|March 30, 2022
Clinical Utility of Liquid Biopsy to Identify Genomic Heterogeneity and Secondary Cancer Diagnoses: A Case ReportGregory Hemenway, Marni B Tierno, Reza Nejati, et al.
Discovery Medicine|January 1, 2015
Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trialsJ Luke Godwin, Matthew Zibelman, Elizabeth R Plimack, et al.
European Urology|January 15, 2018
Chemoimmunotherapy in Metastatic Urothelial CarcinomaDaniel M Geynisman, Phillip H Abbosh, Elizabeth R Plimack, et al.
Clinical Advances in Hematology & Oncology : H&O|April 11, 2019
Update on perioperative systemic therapy for urothelial carcinomaKeren Rouvinov, Elizabeth R Plimack, Matthew Zibelman, et al.
Urology Case Reports|December 20, 2019
Neoadjuvant checkpoint inhibition in renal cell carcinoma associated Stauffer's syndromeKevin Zarrabi, Selma Masic, Christopher Schaefer, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov WebsitePooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Clinical Genitourinary Cancer|March 28, 2026
Assessing Treatment Outcomes of Patients Undergoing Enfortumab Vedotin Dose Reduction in Metastatic Bladder CancerHal Rives, Jordan Fredette, Fern Anari, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 25, 2026
Stepping Up With Immune Checkpoint Blockade: More Combinations and Fewer ContraindicationsJustine V Cohen, Adam Adika, Matthew Zibelman, et al.
Molecular Cancer Therapeutics|March 30, 2020
An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate CancerNancy A Dawson, Matthew Zibelman, Timothy Lindsay, et al.
Pageof 6